Zydus Lifesciences confirms compliance with SEBI regulations regarding the dematerialization of equity shares for the quarter ended September 30, 2025. The company received a certificate from MUFG Intime India Private Limited (RTA), verifying that share certificates have been duly mutilated and cancelled following verification, with depositories substituted as registered owners. This confirms adherence to regulatory standards for dematerialized shares.
Share Dematerialization Compliance
Zydus Lifesciences has announced its compliance with regulatory requirements concerning the dematerialization of equity shares. The confirmation pertains to the quarter ended September 30, 2025.
RTA Confirmation
The confirmation is based on a certificate received from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company’s Registrar and Transfer Agent (RTA). The certificate confirms that all certificates of equity shares received for dematerialization during the specified quarter have been properly processed.
Key Highlights
The company confirms that all share certificates received for dematerialization were mutilated and cancelled only after due verification. The respective depository has been substituted as the registered owner in respect of those dematerialized equity shares. The company also confirms that the securities comprised in the said certificates of equity shares are listed on BSE Limited and the National Stock Exchange of India Limited.
Source: BSE
